Get started
000

ALLIGATOR BIOSCIENCE NPV

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

0RK9 chart


Full chart

0RK9 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪556.40 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.227 SEK
Net income (FY)
‪−248.59 M‬ SEK
Revenue (FY)
‪58.11 M‬ SEK
Shares float
‪402.08 M‬
Beta (1Y)
0.68

Employees


Employees (FY)
58
Change (1Y)
+5 +9.43%
Revenue / Employee (1Y)
‪98.88 K‬ SEK
Net income / Employee (1Y)
‪−423.02 K‬ SEK

About ALLIGATOR BIOSCIENCE AB


Sector
Health Technology
Industry
Biotechnology
CEO
Søren Bregenholt
Website
alligatorbioscience.com
Headquarters
Lund
Founded
2000
ISIN
SE0000767188
FIGI
BBG00NRVY977
Alligator Bioscience AB is a biotechnology company, which engages in the development of novel immuno-oncology drugs. The firm specializes in the development of tumor-directed immunotherapies. Its pipeline includes Mitazalimab, ATOR-1017, ALG.APV-527, Neo-X-Prime, and other research projects. The company was founded by Carl Arne Krister Borrebaeck in 2001 and is headquartered in Lund, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0RK9 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0RK9 is 0.708 SEK — it has increased by 15.87% in the past 24 hours. Watch ALLIGATOR BIOSCIENCE NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ALLIGATOR BIOSCIENCE NPV stocks are traded under the ticker 0RK9.
0RK9 stock has fallen by −31.14% compared to the previous week, the month change is a −36.44% fall, over the last year ALLIGATOR BIOSCIENCE NPV has showed a 77.22% increase.
We've gathered analysts' opinions on ALLIGATOR BIOSCIENCE NPV future price: according to them, 0RK9 price has a max estimate of 2.10 SEK and a min estimate of 1.50 SEK. Watch 0RK9 chart and read a more detailed ALLIGATOR BIOSCIENCE NPV stock forecast: see what analysts think of ALLIGATOR BIOSCIENCE NPV and suggest that you do with its stocks.
0RK9 reached its all-time high on Apr 8, 2019 with the price of 22.890 SEK, and its all-time low was 0.378 SEK and was reached on Nov 2, 2023. View more price dynamics on 0RK9 chart.
See other stocks reaching their highest and lowest prices.
0RK9 stock is 16.53% volatile and has beta coefficient of 0.68. Track ALLIGATOR BIOSCIENCE NPV stock price on the chart and check out the list of the most volatile stocks — is ALLIGATOR BIOSCIENCE NPV there?
Today ALLIGATOR BIOSCIENCE NPV has the market capitalization of ‪530.63 M‬, it has decreased by −4.57% over the last week.
Yes, you can track ALLIGATOR BIOSCIENCE NPV financials in yearly and quarterly reports right on TradingView.
ALLIGATOR BIOSCIENCE NPV is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
0RK9 net income for the last quarter is ‪−66.51 M‬ SEK, while the quarter before that showed ‪−49.21 M‬ SEK of net income which accounts for −35.15% change. Track more ALLIGATOR BIOSCIENCE NPV financial stats to get the full picture.
No, 0RK9 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 58.00 employees. See our rating of the largest employees — is ALLIGATOR BIOSCIENCE NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLIGATOR BIOSCIENCE NPV EBITDA is ‪−232.69 M‬ SEK, and current EBITDA margin is −416.97%. See more stats in ALLIGATOR BIOSCIENCE NPV financial statements.
Like other stocks, 0RK9 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLIGATOR BIOSCIENCE NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALLIGATOR BIOSCIENCE NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALLIGATOR BIOSCIENCE NPV stock shows the strong sell signal. See more of ALLIGATOR BIOSCIENCE NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.